Cumberland Pharmaceuticals Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 43.54M45.88M51.14M48.85M32.03M36.90M33.52M33.03M41.15M29.34M34.39M37.44M35.99M42.01M39.55M37.87M
Cost of Revenue 20.19M22.67M20.94M20.33M14.39M14.90M13.99M14.55M21.49M14.00M15.28M14.77M15.02M16.66M18.45M17.02M
Gross Profit 23.34M23.20M30.20M28.52M17.64M22.00M19.52M18.47M19.66M15.34M19.11M22.68M20.97M25.35M21.10M20.84M
Operating items
Amortization - Intangibles 0.69M0.69M0.66M0.51M0.90M1.60M1.99M2.19M2.44M2.77M4.13M4.43M4.37M5.07M8.10M4.75M
Research & Development 4.99M4.33M5.03M5.10M5.62M3.39M3.85M3.19M4.28M7.58M6.87M5.77M5.68M6.69M5.83M4.82M
Selling, General & Administrative 7.64M8.10M9.31M9.06M9.49M8.40M7.61M8.56M9.65M10.15M9.97M10.20M9.78M10.18M10.65M11.13M
Other Operating Expenses 25.12M26.95M26.96M25.88M20.72M21.55M20.95M22.71M31.30M22.79M26.83M27.85M28.20M30.85M0.47M28.36M
Operating Expenses 37.76M39.37M41.29M40.03M35.83M33.34M32.41M34.46M45.23M40.52M43.68M43.82M43.66M47.72M49.11M44.30M
Operating Income 5.78M6.50M9.85M8.82M-3.80M3.56M1.11M-1.43M-4.08M-11.17M-9.29M-6.38M-7.68M-5.70M-9.55M-6.43M
EBIT 5.78M6.50M9.85M8.82M-3.80M3.56M1.11M-1.43M-4.08M-11.17M-9.29M-6.38M-7.68M-5.70M-9.55M-6.43M
Non-operating items
Interest & Investment Income 0.08M0.20M0.21M0.30M0.23M0.25M0.21M0.20M0.30M0.56M0.24M0.08M0.03M0.10M0.29M0.33M
Net income details
EBT 5.08M5.28M9.71M9.05M-3.67M3.74M1.25M-1.33M-3.87M-10.80M-9.29M-6.57M-5.56M-5.58M-6.28M-6.47M
Tax Provisions 2.02M2.85M4.08M3.24M-1.52M1.38M0.58M-0.33M4.17M0.02M-0.08M0.06M0.03M0.07M0.05M-0.02M
Profit After Tax 3.09M2.46M5.66M5.84M-2.15M2.42M0.73M-1.00M-8.05M-10.82M-9.21M-6.63M-5.60M-5.65M-6.33M-6.48M
Net Income - Minority 0.06M0.09M0.13M0.18M0.01M0.07M0.13M0.20M0.27M0.04M0.12M
Income from Non-Controlling Interests -0.03M-0.03M-0.03M-0.04M-0.05M-0.06M-0.06M-0.06M-0.07M-0.08M-0.01M-0.08M-0.10M-0.08M-0.05M0.04M
Income from Continuing Operations 3.06M2.43M5.63M5.81M-2.15M2.36M0.67M-1.00M-8.05M-10.82M-9.21M-6.63M-5.60M-5.65M-6.33M-6.44M
Consolidated Net Income 3.06M2.43M5.63M5.81M-2.15M2.36M0.67M-1.00M-8.05M3.78M5.67M3.21M1.99M-5.65M-6.33M-6.44M
Income towards Parent Company 3.06M2.49M5.72M5.94M-1.97M2.37M0.74M-0.88M-7.85M4.06M5.70M3.32M1.99M-5.65M-6.33M-6.44M
Net Income towards Common Stockholders 0.220.125.72M5.94M-1.97M2.37M0.74M-0.88M-7.85M4.06M5.70M3.32M1.99M-5.65M-6.33M-6.44M
Additional items
EPS (Basic) 0.220.120.280.30-0.110.140.04-0.06-0.50-0.69-0.60-0.43-0.37-0.38-0.44-0.46
EPS (Weighted Average and Diluted) 0.170.120.280.30-0.110.140.04-0.06-0.50-0.69-0.60-0.43-0.37-0.38-0.44-0.46
Shares Outstanding (Weighted Average) 20.13M20.31M20.18M19.11M18.11M17.36M16.45M16.18M15.75M15.53M15.18M15.04M14.81M14.46M14.26M14.04M
Shares Outstanding (Diluted Average) 18.23M21.06M20.57M19.79M18.33M17.90M17.09M16.24M15.91M15.61M15.40M15.16M14.90M14.56M14.30M14.06M
EBITDA 5.78M2.43M5.63M5.84M-2.15M2.42M0.73M-1.00M-8.05M-7.04M-3.55M-6.38M-7.68M-5.70M-9.55M-6.43M
Interest Expenses 0.77M1.42M0.35M0.07M0.10M0.07M0.07M0.11M0.09M0.20M0.25M0.26M0.10M0.59M0.67M0.61M
Tax Rate 39.82%54.02%42.03%35.85%41.45%36.89%46.18%24.79%0.85%0.35%